Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $8.61 Analyst target: $10.37 Upside: 20.44%
Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.
See the full interactive analysis & chart →Informational only — not investment advice.